In 2021, Lipscombe was appointed the director of the University of Toronto's Novo Nordisk Network for Healthy Populations.
[2] While completing her master's degree, Lipscombe discovered that there was a bidirectional relationship between breast cancer and diabetes.
She also found that women with diabetes received fewer mammograms and had a higher mortality and more advanced stage of breast cancer at diagnosis.
[1] Lipscombe is a professor in the University of Toronto Faculty of Medicine and was director of the Division of Endocrinology at WCH from 2017 to 2021.
[3] While working in these roles, Lipscombe developed a program to assist women with gestational diabetes which included lifestyle coaching on healthy eating and physical activity.